Gene Symbol | Gene ID | Gene Info |
---|---|---|
CXXC1
|
ENSG00000154832.10 | CXXC finger protein 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr18_47814440_47814879 | CXXC1 | 15 | 0.971516 | 0.77 | 1.6e-02 | Click! |
chr18_47824503_47824746 | CXXC1 | 9950 | 0.151702 | 0.71 | 3.1e-02 | Click! |
chr18_47813187_47813429 | CXXC1 | 632 | 0.663934 | 0.71 | 3.2e-02 | Click! |
chr18_47813442_47814055 | CXXC1 | 192 | 0.928903 | 0.67 | 4.7e-02 | Click! |
chr18_47814122_47814273 | CXXC1 | 143 | 0.947550 | 0.59 | 9.3e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_131485272_131485551 | 2.25 |
GPR148 |
G protein-coupled receptor 148 |
1232 |
0.38 |
chr1_10698458_10698868 | 2.21 |
RP4-734G22.3 |
|
635 |
0.7 |
chr7_27170035_27170414 | 2.06 |
HOXA4 |
homeobox A4 |
128 |
0.82 |
chrX_128657032_128657443 | 1.96 |
SMARCA1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
223 |
0.95 |
chr15_26107761_26108124 | 1.92 |
ATP10A |
ATPase, class V, type 10A |
413 |
0.85 |
chr8_55014181_55014390 | 1.91 |
LYPLA1 |
lysophospholipase I |
103 |
0.97 |
chr5_151138322_151138546 | 1.90 |
ATOX1 |
antioxidant 1 copper chaperone |
217 |
0.92 |
chr3_129034345_129034731 | 1.90 |
H1FX-AS1 |
H1FX antisense RNA 1 |
175 |
0.82 |
chr17_19627852_19628005 | 1.88 |
SLC47A2 |
solute carrier family 47 (multidrug and toxin extrusion), member 2 |
7885 |
0.14 |
chr16_46723872_46724084 | 1.87 |
ORC6 |
origin recognition complex, subunit 6 |
369 |
0.73 |
chr3_47051058_47051537 | 1.86 |
NBEAL2 |
neurobeachin-like 2 |
4526 |
0.22 |
chr10_114788196_114788581 | 1.86 |
RP11-57H14.2 |
|
76754 |
0.1 |
chr3_56590949_56591123 | 1.85 |
CCDC66 |
coiled-coil domain containing 66 |
153 |
0.97 |
chr14_52327497_52328482 | 1.83 |
GNG2 |
guanine nucleotide binding protein (G protein), gamma 2 |
53 |
0.98 |
chr3_150127600_150127836 | 1.80 |
TSC22D2 |
TSC22 domain family, member 2 |
1038 |
0.66 |
chr6_15245126_15245320 | 1.80 |
JARID2 |
jumonji, AT rich interactive domain 2 |
1304 |
0.45 |
chr10_7860552_7860852 | 1.79 |
TAF3 |
TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa |
235 |
0.94 |
chr5_322963_323164 | 1.79 |
AHRR |
aryl-hydrocarbon receptor repressor |
308 |
0.89 |
chr7_98741186_98741622 | 1.78 |
SMURF1 |
SMAD specific E3 ubiquitin protein ligase 1 |
238 |
0.94 |
chr8_145448474_145448628 | 1.77 |
ENSG00000264987 |
. |
7548 |
0.11 |
chr13_52586601_52587118 | 1.74 |
ALG11 |
ALG11, alpha-1,2-mannosyltransferase |
309 |
0.84 |
chr8_23386540_23386755 | 1.73 |
SLC25A37 |
solute carrier family 25 (mitochondrial iron transporter), member 37 |
74 |
0.97 |
chr2_88355093_88355269 | 1.70 |
KRCC1 |
lysine-rich coiled-coil 1 |
67 |
0.96 |
chr9_115913433_115913678 | 1.69 |
SLC31A2 |
solute carrier family 31 (copper transporter), member 2 |
333 |
0.9 |
chr5_42992200_42992722 | 1.66 |
CTD-2035E11.3 |
|
26070 |
0.15 |
chr2_220042618_220042887 | 1.63 |
CNPPD1 |
cyclin Pas1/PHO80 domain containing 1 |
76 |
0.53 |
chr12_108523289_108523785 | 1.63 |
WSCD2 |
WSC domain containing 2 |
26 |
0.99 |
chrX_118370864_118371263 | 1.62 |
PGRMC1 |
progesterone receptor membrane component 1 |
775 |
0.73 |
chr19_918011_918162 | 1.62 |
KISS1R |
KISS1 receptor |
583 |
0.52 |
chr20_4667586_4667885 | 1.61 |
PRNP |
prion protein |
546 |
0.8 |
chr2_198669308_198669688 | 1.61 |
PLCL1 |
phospholipase C-like 1 |
72 |
0.98 |
chr16_2867824_2867975 | 1.61 |
PRSS21 |
protease, serine, 21 (testisin) |
19 |
0.94 |
chr22_36424159_36424401 | 1.61 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
193 |
0.97 |
chr11_64815475_64815712 | 1.59 |
NAALADL1 |
N-acetylated alpha-linked acidic dipeptidase-like 1 |
184 |
0.84 |
chr8_22926209_22926496 | 1.59 |
TNFRSF10B |
tumor necrosis factor receptor superfamily, member 10b |
182 |
0.81 |
chrX_48693575_48693797 | 1.57 |
PCSK1N |
proprotein convertase subtilisin/kexin type 1 inhibitor |
349 |
0.78 |
chr18_657189_657560 | 1.57 |
RP11-806L2.5 |
|
115 |
0.63 |
chr8_1735994_1736145 | 1.57 |
CTD-2336O2.1 |
|
23401 |
0.16 |
chr5_138677601_138677984 | 1.57 |
PAIP2 |
poly(A) binding protein interacting protein 2 |
225 |
0.87 |
chr9_124855346_124855631 | 1.56 |
TTLL11 |
tubulin tyrosine ligase-like family, member 11 |
397 |
0.86 |
chr22_38794233_38794423 | 1.55 |
CSNK1E |
casein kinase 1, epsilon |
199 |
0.91 |
chr5_42950238_42951303 | 1.55 |
SEPP1 |
selenoprotein P, plasma, 1 |
63276 |
0.1 |
chr3_119812895_119813189 | 1.54 |
GSK3B |
glycogen synthase kinase 3 beta |
222 |
0.94 |
chr13_40229824_40230064 | 1.54 |
COG6 |
component of oligomeric golgi complex 6 |
130 |
0.96 |
chr1_35658429_35658728 | 1.54 |
SFPQ |
splicing factor proline/glutamine-rich |
171 |
0.94 |
chr12_49716549_49716754 | 1.53 |
TROAP |
trophinin associated protein |
368 |
0.74 |
chr9_130922178_130922352 | 1.53 |
C9orf16 |
chromosome 9 open reading frame 16 |
274 |
0.81 |
chr10_75633716_75633937 | 1.53 |
CAMK2G |
calcium/calmodulin-dependent protein kinase II gamma |
393 |
0.78 |
chr7_372811_373008 | 1.52 |
AC187652.1 |
Protein LOC100996433 |
69991 |
0.12 |
chr10_105127693_105127877 | 1.52 |
TAF5 |
TAF5 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 100kDa |
61 |
0.96 |
chr16_1756328_1756636 | 1.52 |
MAPK8IP3 |
mitogen-activated protein kinase 8 interacting protein 3 |
288 |
0.8 |
chr6_57036745_57036967 | 1.52 |
BAG2 |
BCL2-associated athanogene 2 |
268 |
0.59 |
chr1_28833432_28833903 | 1.51 |
SNHG3 |
small nucleolar RNA host gene 3 (non-protein coding) |
211 |
0.82 |
chrX_75648113_75648326 | 1.50 |
MAGEE1 |
melanoma antigen family E, 1 |
173 |
0.98 |
chr8_124553468_124553740 | 1.49 |
FBXO32 |
F-box protein 32 |
158 |
0.96 |
chr17_48797014_48797214 | 1.49 |
LUC7L3 |
LUC7-like 3 (S. cerevisiae) |
106 |
0.95 |
chr1_184723746_184723985 | 1.48 |
EDEM3 |
ER degradation enhancer, mannosidase alpha-like 3 |
164 |
0.96 |
chr2_242625928_242626170 | 1.48 |
DTYMK |
deoxythymidylate kinase (thymidylate kinase) |
78 |
0.94 |
chr2_203499811_203500114 | 1.47 |
FAM117B |
family with sequence similarity 117, member B |
51 |
0.99 |
chr12_92531544_92532018 | 1.47 |
C12orf79 |
chromosome 12 open reading frame 79 |
984 |
0.53 |
chr4_76861595_76862067 | 1.47 |
NAAA |
N-acylethanolamine acid amidase |
295 |
0.86 |
chr11_57078685_57078948 | 1.46 |
TNKS1BP1 |
tankyrase 1 binding protein 1, 182kDa |
10855 |
0.11 |
chr17_21477031_21477413 | 1.45 |
ENSG00000216100 |
. |
3862 |
0.25 |
chr10_90639948_90640436 | 1.45 |
STAMBPL1 |
STAM binding protein-like 1 |
701 |
0.67 |
chr10_32667341_32667675 | 1.44 |
EPC1 |
enhancer of polycomb homolog 1 (Drosophila) |
218 |
0.91 |
chr14_81685913_81686408 | 1.44 |
GTF2A1 |
general transcription factor IIA, 1, 19/37kDa |
1106 |
0.54 |
chr20_10153010_10153212 | 1.43 |
SNAP25 |
synaptosomal-associated protein, 25kDa |
46367 |
0.15 |
chr7_104650249_104650400 | 1.42 |
LINC01004 |
long intergenic non-protein coding RNA 1004 |
3147 |
0.2 |
chr19_510720_510899 | 1.42 |
AC005775.2 |
|
2996 |
0.12 |
chr9_35072278_35072547 | 1.42 |
VCP |
valosin containing protein |
212 |
0.87 |
chr7_76256241_76256478 | 1.42 |
POMZP3 |
POM121 and ZP3 fusion |
198 |
0.95 |
chr3_71354527_71355079 | 1.41 |
FOXP1 |
forkhead box P1 |
892 |
0.68 |
chr5_6583477_6583682 | 1.40 |
NSUN2 |
NOP2/Sun RNA methyltransferase family, member 2 |
49576 |
0.15 |
chr5_115177794_115178021 | 1.40 |
ATG12 |
autophagy related 12 |
352 |
0.71 |
chr22_29704279_29704430 | 1.39 |
GAS2L1 |
growth arrest-specific 2 like 1 |
1306 |
0.29 |
chr6_31619842_31620065 | 1.38 |
BAG6 |
BCL2-associated athanogene 6 |
18 |
0.71 |
chr5_43066684_43067041 | 1.38 |
CTD-2201E18.3 |
|
659 |
0.57 |
chr22_21336264_21336560 | 1.38 |
LZTR1 |
leucine-zipper-like transcription regulator 1 |
110 |
0.92 |
chr6_56955318_56956098 | 1.38 |
ZNF451 |
zinc finger protein 451 |
703 |
0.71 |
chr13_47127657_47128126 | 1.37 |
LRCH1 |
leucine-rich repeats and calponin homology (CH) domain containing 1 |
496 |
0.87 |
chrX_118533307_118533572 | 1.37 |
SLC25A43 |
solute carrier family 25, member 43 |
96 |
0.95 |
chr1_206809386_206809825 | 1.36 |
DYRK3 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
431 |
0.57 |
chr2_109746082_109746317 | 1.36 |
SH3RF3 |
SH3 domain containing ring finger 3 |
202 |
0.96 |
chr2_96873596_96873988 | 1.36 |
ENSG00000204685 |
. |
362 |
0.69 |
chr6_170151759_170152207 | 1.36 |
ERMARD |
ER membrane-associated RNA degradation |
90 |
0.78 |
chr2_20306812_20306963 | 1.36 |
RP11-644K8.1 |
|
54992 |
0.1 |
chr14_65438646_65438885 | 1.36 |
RAB15 |
RAB15, member RAS oncogene family |
110 |
0.94 |
chr4_74124114_74124272 | 1.35 |
ANKRD17 |
ankyrin repeat domain 17 |
154 |
0.89 |
chr11_18127000_18127190 | 1.35 |
SAAL1 |
serum amyloid A-like 1 |
471 |
0.74 |
chr7_6865666_6865937 | 1.35 |
CCZ1B |
CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae) |
25 |
0.98 |
chr9_129986540_129986714 | 1.35 |
GARNL3 |
GTPase activating Rap/RanGAP domain-like 3 |
83 |
0.96 |
chr3_160282851_160283119 | 1.35 |
KPNA4 |
karyopherin alpha 4 (importin alpha 3) |
391 |
0.87 |
chr10_182243_182463 | 1.35 |
ZMYND11 |
zinc finger, MYND-type containing 11 |
904 |
0.64 |
chr18_77794456_77795152 | 1.35 |
RBFA |
ribosome binding factor A (putative) |
338 |
0.76 |
chr7_150382525_150383418 | 1.34 |
GIMAP2 |
GTPase, IMAP family member 2 |
156 |
0.95 |
chr8_133688256_133688407 | 1.34 |
LRRC6 |
leucine rich repeat containing 6 |
493 |
0.81 |
chr1_249200441_249200637 | 1.34 |
PGBD2 |
piggyBac transposable element derived 2 |
75 |
0.97 |
chr8_42751156_42751435 | 1.34 |
ENSG00000266044 |
. |
123 |
0.77 |
chr2_235404792_235405203 | 1.34 |
ARL4C |
ADP-ribosylation factor-like 4C |
247 |
0.96 |
chr7_44349495_44349752 | 1.34 |
CAMK2B |
calcium/calmodulin-dependent protein kinase II beta |
13938 |
0.22 |
chr8_12612754_12612923 | 1.33 |
LONRF1 |
LON peptidase N-terminal domain and ring finger 1 |
161 |
0.96 |
chr15_78441778_78442007 | 1.33 |
IDH3A |
isocitrate dehydrogenase 3 (NAD+) alpha |
159 |
0.94 |
chr1_173991344_173991495 | 1.33 |
RC3H1 |
ring finger and CCCH-type domains 1 |
16 |
0.98 |
chr19_1439067_1439250 | 1.32 |
RPS15 |
ribosomal protein S15 |
352 |
0.66 |
chr6_37787230_37787429 | 1.32 |
ZFAND3 |
zinc finger, AN1-type domain 3 |
54 |
0.82 |
chr1_10459608_10460098 | 1.32 |
PGD |
phosphogluconate dehydrogenase |
164 |
0.92 |
chr18_44526809_44527253 | 1.32 |
KATNAL2 |
katanin p60 subunit A-like 2 |
213 |
0.91 |
chr11_62358316_62359010 | 1.31 |
TUT1 |
terminal uridylyl transferase 1, U6 snRNA-specific |
332 |
0.71 |
chr18_77793817_77793982 | 1.31 |
TXNL4A |
thioredoxin-like 4A |
8 |
0.89 |
chr7_97881716_97882107 | 1.31 |
TECPR1 |
tectonin beta-propeller repeat containing 1 |
348 |
0.87 |
chr16_103384_103581 | 1.30 |
POLR3K |
polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa |
146 |
0.71 |
chr17_29297549_29297926 | 1.30 |
RNF135 |
ring finger protein 135 |
265 |
0.77 |
chr6_119399577_119399871 | 1.30 |
FAM184A |
family with sequence similarity 184, member A |
184 |
0.95 |
chr2_75062400_75062659 | 1.30 |
HK2 |
hexokinase 2 |
232 |
0.95 |
chr7_5437012_5437163 | 1.30 |
TNRC18 |
trinucleotide repeat containing 18 |
9427 |
0.16 |
chr6_42532119_42532973 | 1.30 |
UBR2 |
ubiquitin protein ligase E3 component n-recognin 2 |
746 |
0.71 |
chr2_197034753_197035766 | 1.29 |
STK17B |
serine/threonine kinase 17b |
465 |
0.83 |
chr11_65838099_65838286 | 1.29 |
PACS1 |
phosphofurin acidic cluster sorting protein 1 |
267 |
0.78 |
chr14_103852201_103853000 | 1.29 |
MARK3 |
MAP/microtubule affinity-regulating kinase 3 |
24 |
0.98 |
chr11_104838069_104839428 | 1.29 |
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
1345 |
0.45 |
chr14_57857369_57857520 | 1.29 |
NAA30 |
N(alpha)-acetyltransferase 30, NatC catalytic subunit |
138 |
0.97 |
chr5_473388_473548 | 1.29 |
ENSG00000225138 |
. |
117 |
0.68 |
chr21_36419137_36419702 | 1.29 |
RUNX1 |
runt-related transcription factor 1 |
2043 |
0.49 |
chr9_100000727_100000985 | 1.29 |
CCDC180 |
coiled-coil domain containing 180 |
77 |
0.98 |
chr13_23949221_23949469 | 1.29 |
SACS |
spastic ataxia of Charlevoix-Saguenay (sacsin) |
337 |
0.93 |
chr6_27101035_27101630 | 1.28 |
HIST1H2AG |
histone cluster 1, H2ag |
500 |
0.53 |
chr22_42078056_42078432 | 1.28 |
NHP2L1 |
NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae) |
382 |
0.74 |
chr21_30671759_30672553 | 1.28 |
BACH1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
152 |
0.96 |
chrX_40014744_40014994 | 1.28 |
BCOR |
BCL6 corepressor |
8987 |
0.31 |
chr15_44092835_44093206 | 1.28 |
HYPK |
huntingtin interacting protein K |
223 |
0.57 |
chr3_41241991_41242658 | 1.28 |
CTNNB1 |
catenin (cadherin-associated protein), beta 1, 88kDa |
722 |
0.82 |
chr10_1034645_1035013 | 1.28 |
GTPBP4 |
GTP binding protein 4 |
174 |
0.81 |
chr19_6425433_6425584 | 1.28 |
KHSRP |
KH-type splicing regulatory protein |
703 |
0.46 |
chr22_40741905_40742056 | 1.27 |
ADSL |
adenylosuccinate lyase |
527 |
0.78 |
chr10_30024584_30024839 | 1.27 |
SVIL |
supervillin |
19 |
0.98 |
chr16_88717197_88717411 | 1.27 |
CYBA |
cytochrome b-245, alpha polypeptide |
119 |
0.92 |
chr16_4743148_4743442 | 1.27 |
NUDT16L1 |
nudix (nucleoside diphosphate linked moiety X)-type motif 16-like 1 |
400 |
0.77 |
chr16_1031099_1031287 | 1.26 |
AC009041.2 |
|
59 |
0.53 |
chrX_149106233_149106670 | 1.26 |
CXorf40B |
chromosome X open reading frame 40B |
202 |
0.71 |
chr7_75071593_75071917 | 1.26 |
POM121C |
POM121 transmembrane nucleoporin C |
238 |
0.89 |
chr2_38460463_38460838 | 1.26 |
ENSG00000199603 |
. |
86093 |
0.09 |
chr5_37370451_37371178 | 1.25 |
NUP155 |
nucleoporin 155kDa |
73 |
0.98 |
chr4_77869682_77869833 | 1.25 |
SEPT11 |
septin 11 |
1099 |
0.58 |
chr11_34073526_34073677 | 1.25 |
CAPRIN1 |
cell cycle associated protein 1 |
1 |
0.99 |
chr10_125851443_125851830 | 1.24 |
CHST15 |
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
334 |
0.93 |
chr3_72226253_72226548 | 1.24 |
ENSG00000212070 |
. |
85179 |
0.1 |
chr21_45722675_45722826 | 1.24 |
PFKL |
phosphofructokinase, liver |
2461 |
0.15 |
chr22_46466568_46466796 | 1.24 |
RP6-109B7.4 |
|
911 |
0.4 |
chrX_102631036_102631748 | 1.24 |
NGFRAP1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
57 |
0.97 |
chr22_39915742_39916052 | 1.24 |
ATF4 |
activating transcription factor 4 |
197 |
0.92 |
chr3_39424611_39424762 | 1.24 |
SLC25A38 |
solute carrier family 25, member 38 |
153 |
0.94 |
chr3_8808825_8808976 | 1.24 |
OXTR |
oxytocin receptor |
1463 |
0.34 |
chr16_57496565_57496748 | 1.24 |
POLR2C |
polymerase (RNA) II (DNA directed) polypeptide C, 33kDa |
357 |
0.81 |
chr12_116713607_116714099 | 1.24 |
MED13L |
mediator complex subunit 13-like |
711 |
0.73 |
chr12_106532127_106532580 | 1.24 |
NUAK1 |
NUAK family, SNF1-like kinase, 1 |
1458 |
0.48 |
chr8_61429545_61429985 | 1.23 |
RAB2A |
RAB2A, member RAS oncogene family |
25 |
0.98 |
chr17_38574463_38574649 | 1.23 |
TOP2A |
topoisomerase (DNA) II alpha 170kDa |
354 |
0.81 |
chr21_38070758_38071201 | 1.23 |
SIM2 |
single-minded family bHLH transcription factor 2 |
455 |
0.82 |
chr3_141121878_141122254 | 1.22 |
ZBTB38 |
zinc finger and BTB domain containing 38 |
406 |
0.88 |
chr7_108095239_108095469 | 1.22 |
NRCAM |
neuronal cell adhesion molecule |
1411 |
0.52 |
chr10_17659023_17659270 | 1.22 |
PTPLA |
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
88 |
0.97 |
chr10_70716244_70716543 | 1.22 |
DDX21 |
DEAD (Asp-Glu-Ala-Asp) box helicase 21 |
509 |
0.74 |
chr18_32556796_32556947 | 1.22 |
MAPRE2 |
microtubule-associated protein, RP/EB family, member 2 |
21 |
0.99 |
chr4_89377941_89378199 | 1.22 |
HERC5 |
HECT and RLD domain containing E3 ubiquitin protein ligase 5 |
198 |
0.94 |
chr18_47012500_47013343 | 1.22 |
C18orf32 |
chromosome 18 open reading frame 32 |
62 |
0.8 |
chr12_92538049_92538662 | 1.22 |
BTG1 |
B-cell translocation gene 1, anti-proliferative |
654 |
0.51 |
chr7_2563263_2563619 | 1.22 |
ENSG00000264357 |
. |
3267 |
0.18 |
chr15_72767035_72767193 | 1.21 |
ARIH1 |
ariadne RBR E3 ubiquitin protein ligase 1 |
128 |
0.97 |
chr1_61549203_61549354 | 1.21 |
ENSG00000263380 |
. |
76 |
0.94 |
chr20_2633879_2634251 | 1.21 |
ENSG00000221062 |
. |
642 |
0.28 |
chr1_11740414_11740565 | 1.21 |
MAD2L2 |
MAD2 mitotic arrest deficient-like 2 (yeast) |
679 |
0.57 |
chr5_78533043_78533683 | 1.21 |
JMY |
junction mediating and regulatory protein, p53 cofactor |
1351 |
0.42 |
chr6_20213110_20213540 | 1.21 |
MBOAT1 |
membrane bound O-acyltransferase domain containing 1 |
655 |
0.59 |
chr19_12175578_12175831 | 1.21 |
ZNF844 |
zinc finger protein 844 |
79 |
0.93 |
chr7_26241378_26241671 | 1.21 |
CBX3 |
chromobox homolog 3 |
139 |
0.93 |
chr13_78272359_78272528 | 1.20 |
SLAIN1 |
SLAIN motif family, member 1 |
27 |
0.71 |
chr1_39269909_39270114 | 1.20 |
RRAGC |
Ras-related GTP binding C |
55484 |
0.1 |
chr2_20101762_20102220 | 1.20 |
TTC32 |
tetratricopeptide repeat domain 32 |
244 |
0.94 |
chr5_92915594_92915963 | 1.20 |
ENSG00000237187 |
. |
935 |
0.59 |
chr3_194354154_194354713 | 1.20 |
TMEM44 |
transmembrane protein 44 |
15 |
0.93 |
chr10_126848506_126848766 | 1.20 |
CTBP2 |
C-terminal binding protein 2 |
432 |
0.9 |
chr19_41111211_41111409 | 1.20 |
ENSG00000266164 |
. |
1645 |
0.28 |
chr6_41606839_41606998 | 1.19 |
MDFI |
MyoD family inhibitor |
653 |
0.66 |
chr7_104653771_104653989 | 1.19 |
LINC01004 |
long intergenic non-protein coding RNA 1004 |
389 |
0.57 |
chr16_67183969_67184120 | 1.19 |
B3GNT9 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 |
1073 |
0.26 |
chr12_122984366_122984751 | 1.19 |
ZCCHC8 |
zinc finger, CCHC domain containing 8 |
237 |
0.91 |
chr9_135117163_135117384 | 1.18 |
ENSG00000221105 |
. |
27011 |
0.2 |
chr18_9136832_9137023 | 1.18 |
ANKRD12 |
ankyrin repeat domain 12 |
133 |
0.7 |
chr4_78739552_78739838 | 1.18 |
CNOT6L |
CCR4-NOT transcription complex, subunit 6-like |
522 |
0.85 |
chr15_42119857_42120069 | 1.17 |
RP11-23P13.4 |
|
90 |
0.57 |
chr4_102267764_102268012 | 1.17 |
PPP3CA |
protein phosphatase 3, catalytic subunit, alpha isozyme |
65 |
0.95 |
chr2_239756978_239757253 | 1.17 |
TWIST2 |
twist family bHLH transcription factor 2 |
442 |
0.88 |
chr3_126423026_126423240 | 1.17 |
CHCHD6 |
coiled-coil-helix-coiled-coil-helix domain containing 6 |
49 |
0.98 |
chr17_73900469_73900787 | 1.17 |
MRPL38 |
mitochondrial ribosomal protein L38 |
866 |
0.37 |
chr3_23245219_23245473 | 1.17 |
UBE2E2 |
ubiquitin-conjugating enzyme E2E 2 |
562 |
0.7 |
chr12_50451575_50451993 | 1.17 |
ASIC1 |
acid-sensing (proton-gated) ion channel 1 |
297 |
0.85 |
chr1_55681102_55681610 | 1.17 |
USP24 |
ubiquitin specific peptidase 24 |
570 |
0.79 |
chr9_2014421_2015066 | 1.17 |
SMARCA2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
599 |
0.81 |
chr10_22517805_22518096 | 1.16 |
EBLN1 |
endogenous Bornavirus-like nucleoprotein 1 |
19000 |
0.22 |
chr11_130184398_130184604 | 1.16 |
ZBTB44 |
zinc finger and BTB domain containing 44 |
6 |
0.98 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.4 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
1.3 | 3.8 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
1.1 | 3.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
1.1 | 5.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.1 | 3.3 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
1.0 | 4.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.0 | 3.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
1.0 | 3.8 | GO:0061316 | canonical Wnt signaling pathway involved in heart development(GO:0061316) |
0.9 | 0.9 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.9 | 0.9 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.9 | 3.6 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.8 | 1.7 | GO:0061371 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) determination of heart left/right asymmetry(GO:0061371) |
0.8 | 2.5 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.8 | 2.4 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.8 | 1.6 | GO:1902019 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) cilium movement involved in cell motility(GO:0060294) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.8 | 3.9 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.8 | 2.3 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.8 | 2.3 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.8 | 2.3 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.8 | 3.8 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.8 | 3.0 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.8 | 3.0 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.8 | 3.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.7 | 0.7 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.7 | 2.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.7 | 0.7 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.7 | 2.8 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.7 | 0.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.7 | 2.1 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.7 | 2.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.7 | 3.4 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.7 | 2.0 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.7 | 2.0 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.7 | 2.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.6 | 2.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.6 | 0.6 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.6 | 5.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.6 | 1.9 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.6 | 1.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.6 | 1.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.6 | 3.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.6 | 2.5 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.6 | 1.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.6 | 1.8 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.6 | 1.8 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.6 | 2.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.6 | 7.8 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.6 | 1.8 | GO:1902745 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.6 | 0.6 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.6 | 3.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.6 | 1.2 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.6 | 3.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.6 | 1.8 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.6 | 1.8 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.6 | 0.6 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.6 | 2.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.6 | 1.7 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.6 | 0.6 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.6 | 2.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.6 | 1.7 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.6 | 2.8 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.6 | 1.7 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.6 | 2.2 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.6 | 2.2 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.5 | 1.6 | GO:1901215 | negative regulation of neuron apoptotic process(GO:0043524) negative regulation of neuron death(GO:1901215) |
0.5 | 1.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.5 | 2.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.5 | 2.2 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.5 | 1.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.5 | 2.2 | GO:0070527 | platelet aggregation(GO:0070527) |
0.5 | 1.6 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.5 | 1.1 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.5 | 1.6 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.5 | 1.6 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.5 | 3.2 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.5 | 2.7 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.5 | 1.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.5 | 2.6 | GO:0002664 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
0.5 | 2.1 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.5 | 1.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.5 | 1.6 | GO:0032880 | regulation of protein localization(GO:0032880) |
0.5 | 4.7 | GO:0006301 | postreplication repair(GO:0006301) |
0.5 | 1.6 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.5 | 3.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.5 | 2.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.5 | 1.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.5 | 0.5 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.5 | 4.6 | GO:0051322 | anaphase(GO:0051322) |
0.5 | 5.6 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.5 | 1.5 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.5 | 1.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.5 | 5.0 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.5 | 1.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.5 | 1.5 | GO:0016559 | peroxisome fission(GO:0016559) |
0.5 | 0.5 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.5 | 9.4 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.5 | 2.5 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.5 | 4.9 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.5 | 1.0 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.5 | 2.0 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.5 | 1.5 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.5 | 0.5 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.5 | 1.9 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.5 | 0.5 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.5 | 1.5 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.5 | 1.9 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.5 | 1.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.5 | 6.3 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.5 | 3.4 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.5 | 1.4 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.5 | 1.9 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.5 | 2.4 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.5 | 1.9 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.5 | 0.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.5 | 1.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.5 | 1.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.5 | 2.8 | GO:0002063 | chondrocyte development(GO:0002063) |
0.5 | 1.4 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.5 | 2.4 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.5 | 1.4 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.5 | 0.5 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.5 | 2.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.5 | 0.9 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.5 | 2.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.5 | 0.9 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.5 | 1.8 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.5 | 1.4 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.5 | 2.3 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.5 | 0.9 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.4 | 3.6 | GO:0006983 | ER overload response(GO:0006983) |
0.4 | 3.6 | GO:0006853 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.4 | 1.8 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.4 | 3.6 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.4 | 10.2 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.4 | 8.0 | GO:0051225 | spindle assembly(GO:0051225) |
0.4 | 1.8 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.4 | 0.9 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.4 | 1.8 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.4 | 3.5 | GO:0031529 | ruffle organization(GO:0031529) |
0.4 | 0.4 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.4 | 4.8 | GO:0010510 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.4 | 1.8 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.4 | 3.1 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.4 | 0.9 | GO:0097576 | vacuole fusion(GO:0097576) |
0.4 | 6.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.4 | 1.7 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.4 | 0.4 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
0.4 | 1.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.4 | 1.3 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.4 | 1.3 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.4 | 1.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.4 | 0.4 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.4 | 1.3 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.4 | 0.4 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.4 | 1.7 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.4 | 1.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.4 | 0.4 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.4 | 0.8 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.4 | 2.9 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.4 | 1.2 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.4 | 3.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.4 | 0.4 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.4 | 3.7 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.4 | 1.6 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.4 | 1.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.4 | 4.9 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.4 | 0.8 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.4 | 2.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.4 | 1.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.4 | 0.8 | GO:0022038 | corpus callosum development(GO:0022038) |
0.4 | 1.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.4 | 1.2 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.4 | 3.2 | GO:0070076 | histone lysine demethylation(GO:0070076) |
0.4 | 0.4 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.4 | 2.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.4 | 1.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.4 | 1.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 0.8 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.4 | 1.6 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.4 | 1.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 1.2 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.4 | 0.4 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.4 | 0.4 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.4 | 1.2 | GO:0090559 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.4 | 0.8 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.4 | 1.6 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.4 | 1.2 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.4 | 1.2 | GO:0015825 | L-serine transport(GO:0015825) |
0.4 | 1.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.4 | 0.4 | GO:0051775 | response to redox state(GO:0051775) |
0.4 | 2.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.4 | 1.2 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.4 | 0.4 | GO:0032608 | interferon-beta production(GO:0032608) |
0.4 | 1.2 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.4 | 1.9 | GO:0043248 | proteasome assembly(GO:0043248) |
0.4 | 3.1 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.4 | 2.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.4 | 0.8 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.4 | 6.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.4 | 4.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.4 | 8.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.4 | 0.4 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.4 | 1.9 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.4 | 4.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 0.4 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.4 | 1.1 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.4 | 2.6 | GO:0032768 | regulation of monooxygenase activity(GO:0032768) |
0.4 | 1.5 | GO:0071027 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.4 | 0.4 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.4 | 1.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.4 | 0.7 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.4 | 2.9 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.4 | 1.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.4 | 1.1 | GO:0044415 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.4 | 1.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.4 | 1.1 | GO:1900087 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.4 | 1.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.4 | 1.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.4 | 1.4 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.4 | 3.3 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.4 | 1.8 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.4 | 0.7 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.4 | 0.7 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.4 | 9.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.4 | 1.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.4 | 14.7 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.4 | 0.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.4 | 0.7 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 | 1.4 | GO:1904376 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.4 | 1.4 | GO:0000012 | single strand break repair(GO:0000012) |
0.4 | 1.1 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.4 | 0.7 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.4 | 1.8 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.4 | 1.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.4 | 3.6 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.4 | 6.7 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.4 | 1.4 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.4 | 0.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.4 | 0.7 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.4 | 1.1 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.4 | 1.1 | GO:0007059 | chromosome segregation(GO:0007059) |
0.4 | 1.1 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.4 | 0.7 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.3 | 1.7 | GO:0009953 | dorsal/ventral pattern formation(GO:0009953) |
0.3 | 0.7 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.3 | 0.7 | GO:0032609 | interferon-gamma production(GO:0032609) regulation of interferon-gamma production(GO:0032649) positive regulation of interferon-gamma production(GO:0032729) |
0.3 | 6.3 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.3 | 1.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.3 | 2.4 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 2.4 | GO:1902583 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.3 | 1.4 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.3 | 0.7 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.3 | 2.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.3 | 1.4 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 1.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 1.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 1.0 | GO:0045576 | mast cell activation(GO:0045576) |
0.3 | 1.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.3 | 0.7 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.3 | 1.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.3 | 0.7 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.3 | 1.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 0.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.3 | 16.2 | GO:0006413 | translational initiation(GO:0006413) |
0.3 | 11.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.3 | 2.0 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.3 | 1.0 | GO:0006562 | proline catabolic process(GO:0006562) |
0.3 | 0.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.3 | 1.3 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.3 | 1.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.3 | 17.0 | GO:0051028 | mRNA transport(GO:0051028) |
0.3 | 0.7 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.3 | 0.3 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.3 | 0.7 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.3 | 1.3 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.3 | 1.3 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.3 | 0.7 | GO:0060596 | mammary placode formation(GO:0060596) |
0.3 | 0.7 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 0.3 | GO:0050951 | detection of temperature stimulus(GO:0016048) sensory perception of temperature stimulus(GO:0050951) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.3 | 21.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.3 | 1.6 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.3 | 0.3 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.3 | 1.3 | GO:0006172 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.3 | 1.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 36.1 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.3 | 0.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.3 | 0.6 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.3 | 1.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 1.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.3 | 1.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 1.9 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 0.6 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.3 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 0.3 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.3 | 7.0 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.3 | 1.3 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.3 | 1.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 0.3 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.3 | 1.3 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.3 | 0.3 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.3 | 0.3 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.3 | 0.9 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.3 | 0.3 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.3 | 0.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 0.9 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.3 | 1.3 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.3 | 2.8 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.3 | 2.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.3 | 2.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.3 | 3.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 0.9 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.3 | 0.9 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.3 | 1.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.3 | 3.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 0.3 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.3 | 0.3 | GO:0010447 | response to acidic pH(GO:0010447) |
0.3 | 0.6 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.3 | 0.9 | GO:0002467 | germinal center formation(GO:0002467) |
0.3 | 0.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.3 | 1.2 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.3 | 0.3 | GO:0046040 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.3 | 0.3 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.3 | 4.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.3 | 1.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.3 | 3.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 0.9 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.3 | 1.8 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.3 | 0.9 | GO:0016137 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.3 | 0.9 | GO:0031297 | replication fork processing(GO:0031297) |
0.3 | 13.9 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.3 | 1.2 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.3 | 2.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 0.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.3 | 0.6 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.3 | 1.5 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.3 | 4.1 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.3 | 2.0 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.3 | 0.6 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.3 | 7.8 | GO:0006490 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.3 | 0.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.3 | 0.9 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.3 | 1.4 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.3 | 0.6 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.3 | 0.9 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.3 | 0.6 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.3 | 0.9 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.3 | 5.7 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.3 | 0.3 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.3 | 1.7 | GO:0072395 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.3 | 0.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.3 | 0.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.3 | 1.4 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.3 | 3.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.3 | 0.6 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.3 | 1.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.3 | 3.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.3 | 2.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.3 | 0.3 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.3 | 0.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 1.7 | GO:0007051 | spindle organization(GO:0007051) |
0.3 | 1.4 | GO:0051642 | centrosome localization(GO:0051642) |
0.3 | 4.2 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.3 | 1.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.3 | 1.1 | GO:0006302 | double-strand break repair(GO:0006302) |
0.3 | 0.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 0.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.3 | 2.2 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 0.6 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.3 | 0.8 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.3 | 1.4 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.3 | 0.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 0.5 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.3 | 1.1 | GO:0001562 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
0.3 | 1.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.3 | 0.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.3 | 1.4 | GO:0006825 | copper ion transport(GO:0006825) |
0.3 | 4.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.3 | 0.3 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.3 | 18.8 | GO:0006415 | translational termination(GO:0006415) |
0.3 | 0.3 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.3 | 0.8 | GO:0010761 | fibroblast migration(GO:0010761) |
0.3 | 0.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.3 | 5.7 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.3 | 0.8 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.3 | 0.5 | GO:0051769 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.3 | 0.3 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.3 | 6.2 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
0.3 | 0.3 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.3 | 1.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.3 | 3.0 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.3 | 1.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.3 | 0.8 | GO:0035929 | steroid hormone secretion(GO:0035929) |
0.3 | 0.8 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.3 | 0.8 | GO:0006903 | vesicle targeting(GO:0006903) |
0.3 | 1.3 | GO:0045008 | depyrimidination(GO:0045008) |
0.3 | 1.9 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.3 | 1.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 0.5 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.3 | 0.8 | GO:0035872 | cytoplasmic pattern recognition receptor signaling pathway(GO:0002753) nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.3 | 1.6 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.3 | 1.1 | GO:1902750 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) mitotic G2/M transition checkpoint(GO:0044818) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.3 | 0.5 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.3 | 1.8 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.3 | 0.8 | GO:0060760 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) positive regulation of response to cytokine stimulus(GO:0060760) |
0.3 | 2.9 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.3 | 0.5 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.3 | 0.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.3 | 1.8 | GO:0033504 | floor plate development(GO:0033504) |
0.3 | 1.6 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.3 | 0.8 | GO:0000239 | pachytene(GO:0000239) |
0.3 | 3.1 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.3 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 1.3 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.3 | 3.3 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.3 | 0.8 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.3 | 1.8 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.3 | 15.9 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.3 | 0.3 | GO:0001820 | serotonin secretion(GO:0001820) |
0.3 | 1.5 | GO:1900181 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein localization to nucleus(GO:1900181) negative regulation of protein import(GO:1904590) |
0.3 | 1.3 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.3 | 0.8 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 0.5 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.3 | 0.3 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.3 | 20.0 | GO:0008380 | RNA splicing(GO:0008380) |
0.3 | 0.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 5.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 1.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.3 | 1.5 | GO:0006862 | nucleotide transport(GO:0006862) |
0.3 | 1.8 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.3 | 1.0 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.3 | 1.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.3 | 6.5 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.3 | 0.3 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.3 | 0.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.3 | 0.8 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.5 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.2 | 0.5 | GO:0032202 | telomere assembly(GO:0032202) |
0.2 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.5 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 0.7 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.7 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 1.2 | GO:0007031 | peroxisome organization(GO:0007031) |
0.2 | 1.0 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.2 | 0.5 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 1.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 47.6 | GO:0019941 | modification-dependent protein catabolic process(GO:0019941) modification-dependent macromolecule catabolic process(GO:0043632) |
0.2 | 0.5 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.2 | 0.5 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.2 | 1.2 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.2 | 1.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 4.9 | GO:1903320 | regulation of protein modification by small protein conjugation or removal(GO:1903320) |
0.2 | 1.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.7 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 1.4 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 0.7 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 3.8 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.2 | 0.7 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 6.2 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 0.7 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.2 | 2.8 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.2 | 1.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.2 | 1.7 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 0.5 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.2 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.2 | 0.5 | GO:0014889 | muscle atrophy(GO:0014889) |
0.2 | 1.6 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.2 | 0.9 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.2 | 0.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 0.2 | GO:0048538 | thymus development(GO:0048538) |
0.2 | 1.2 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.2 | 0.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 8.3 | GO:0006397 | mRNA processing(GO:0006397) |
0.2 | 0.7 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.2 | 0.5 | GO:1903224 | endodermal cell fate commitment(GO:0001711) endodermal cell fate specification(GO:0001714) endodermal cell differentiation(GO:0035987) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.2 | 0.2 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 0.9 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 1.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 0.5 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.2 | 0.2 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.2 | 0.9 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.2 | 0.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.2 | 7.9 | GO:0043038 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.2 | 0.7 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
0.2 | 0.2 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.2 | 0.5 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.2 | 1.1 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.2 | 0.2 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.2 | 0.2 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.2 | 4.2 | GO:0072655 | protein targeting to mitochondrion(GO:0006626) protein localization to mitochondrion(GO:0070585) establishment of protein localization to mitochondrion(GO:0072655) |
0.2 | 1.3 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.2 | 0.7 | GO:0042117 | monocyte activation(GO:0042117) |
0.2 | 0.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 4.0 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 1.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 0.4 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 11.9 | GO:0008033 | tRNA processing(GO:0008033) |
0.2 | 8.8 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.2 | 1.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 0.2 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.2 | 35.9 | GO:0006412 | translation(GO:0006412) |
0.2 | 0.4 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.2 | 0.4 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.2 | 0.2 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 0.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.2 | 0.2 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.2 | 0.2 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.2 | 0.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 5.7 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.2 | 0.2 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 0.4 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.2 | 1.5 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.2 | 0.4 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.2 | 0.8 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 1.3 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.2 | 0.2 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 0.8 | GO:0051123 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.2 | 0.2 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.2 | 5.6 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.2 | 0.4 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.2 | 0.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 2.2 | GO:0046131 | pyrimidine ribonucleoside metabolic process(GO:0046131) |
0.2 | 0.2 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) regulation of anion transmembrane transport(GO:1903959) |
0.2 | 0.6 | GO:0006266 | DNA ligation(GO:0006266) |
0.2 | 0.6 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.2 | 7.5 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.2 | 0.2 | GO:0000723 | telomere maintenance(GO:0000723) |
0.2 | 0.2 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.2 | 0.6 | GO:0071156 | regulation of cell cycle arrest(GO:0071156) |
0.2 | 0.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.4 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.2 | 0.6 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.2 | 0.4 | GO:0046398 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.2 | 0.2 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.2 | 0.6 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 0.6 | GO:0046813 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 0.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 0.6 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.2 | 0.6 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.2 | 0.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.8 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.4 | GO:1900076 | regulation of insulin receptor signaling pathway(GO:0046626) regulation of cellular response to insulin stimulus(GO:1900076) |
0.2 | 0.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.2 | 0.2 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.2 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.4 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.2 | 0.6 | GO:0042772 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.2 | 1.0 | GO:0061462 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.2 | 0.8 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 5.5 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.2 | 0.8 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.2 | 1.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 0.2 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) peptidyl-arginine N-methylation(GO:0035246) |
0.2 | 2.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 1.9 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.2 | 0.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.6 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.2 | 0.2 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.2 | 0.6 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 1.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.2 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.2 | 0.4 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 0.2 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.2 | 0.6 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.2 | 0.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 3.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 7.8 | GO:0006364 | rRNA processing(GO:0006364) |
0.2 | 0.4 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.2 | 2.6 | GO:0019079 | viral genome replication(GO:0019079) |
0.2 | 0.4 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.2 | 1.1 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.2 | 2.0 | GO:0003016 | respiratory system process(GO:0003016) |
0.2 | 2.8 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.2 | 0.4 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.2 | 2.9 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.2 | 0.4 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 0.9 | GO:0032722 | positive regulation of chemokine production(GO:0032722) |
0.2 | 0.7 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 0.4 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.2 | 0.2 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 0.4 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.2 | 1.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.5 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.2 | 0.5 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 0.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 1.2 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.2 | 1.4 | GO:0007098 | centrosome cycle(GO:0007098) |
0.2 | 0.4 | GO:0010608 | posttranscriptional regulation of gene expression(GO:0010608) |
0.2 | 0.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 0.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 2.5 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.2 | 2.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 2.1 | GO:0016236 | macroautophagy(GO:0016236) |
0.2 | 0.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.2 | 0.4 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.2 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 1.6 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.2 | 3.8 | GO:0006826 | iron ion transport(GO:0006826) |
0.2 | 0.2 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.2 | 1.6 | GO:0006906 | vesicle fusion(GO:0006906) |
0.2 | 1.6 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.2 | 1.2 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.2 | 0.9 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.2 | 6.7 | GO:0006396 | RNA processing(GO:0006396) |
0.2 | 0.7 | GO:0046618 | drug export(GO:0046618) |
0.2 | 0.2 | GO:0060426 | lung vasculature development(GO:0060426) bronchiole development(GO:0060435) |
0.2 | 2.2 | GO:0097581 | lamellipodium organization(GO:0097581) |
0.2 | 4.1 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.2 | 1.0 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 1.5 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.2 | 0.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.2 | 0.7 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.2 | 0.5 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 0.5 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.2 | 2.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 0.2 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.2 | 1.2 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.2 | 1.3 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.2 | 0.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.7 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.2 | 1.3 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.2 | 0.7 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.2 | 1.0 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.2 | 20.7 | GO:0016568 | chromatin modification(GO:0016568) |
0.2 | 0.6 | GO:0034644 | cellular response to UV(GO:0034644) |
0.2 | 0.5 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 0.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 0.2 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.2 | 1.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 1.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.2 | 0.6 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.2 | GO:0048278 | vesicle docking(GO:0048278) |
0.2 | 7.8 | GO:0007034 | vacuolar transport(GO:0007034) |
0.2 | 0.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 0.5 | GO:0006310 | DNA recombination(GO:0006310) |
0.2 | 0.3 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.2 | 0.3 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.2 | 0.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 0.9 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
0.2 | 1.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 0.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 0.6 | GO:0006560 | proline metabolic process(GO:0006560) |
0.2 | 1.1 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.2 | 0.3 | GO:0060119 | inner ear receptor cell development(GO:0060119) |
0.2 | 0.6 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 6.6 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.2 | 0.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.6 | GO:0015851 | nucleobase transport(GO:0015851) |
0.2 | 0.6 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.2 | 0.5 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.2 | 8.9 | GO:0016032 | viral process(GO:0016032) |
0.2 | 12.8 | GO:0097190 | apoptotic signaling pathway(GO:0097190) |
0.2 | 0.3 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.2 | 0.2 | GO:0001914 | regulation of T cell mediated cytotoxicity(GO:0001914) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.3 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 14.0 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.1 | 0.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 1.0 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.1 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 0.1 | GO:0015809 | arginine transport(GO:0015809) |
0.1 | 0.1 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.1 | 0.6 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 1.2 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.9 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.1 | 0.9 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 1.2 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.4 | GO:0034333 | adherens junction assembly(GO:0034333) |
0.1 | 0.4 | GO:0034614 | cellular response to reactive oxygen species(GO:0034614) |
0.1 | 8.0 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.1 | 0.1 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 5.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.3 | GO:1903578 | regulation of glycolytic process(GO:0006110) regulation of nucleoside metabolic process(GO:0009118) regulation of ATP metabolic process(GO:1903578) |
0.1 | 0.6 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.1 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.3 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.7 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 1.4 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
0.1 | 0.6 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.7 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.3 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 13.1 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.1 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.1 | 0.1 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.3 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.1 | 0.8 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.3 | GO:0051297 | microtubule organizing center organization(GO:0031023) centrosome organization(GO:0051297) |
0.1 | 0.4 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.9 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.1 | GO:2000107 | negative regulation of leukocyte apoptotic process(GO:2000107) |
0.1 | 0.8 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.4 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
0.1 | 12.9 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.1 | 1.8 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
0.1 | 0.5 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.1 | 1.3 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.1 | 0.1 | GO:0044257 | cellular protein catabolic process(GO:0044257) |
0.1 | 0.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.6 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.1 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.1 | 0.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.4 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 10.6 | GO:0006281 | DNA repair(GO:0006281) |
0.1 | 0.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.5 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.1 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.5 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.2 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.1 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.1 | 0.4 | GO:0000278 | mitotic cell cycle(GO:0000278) |
0.1 | 0.9 | GO:0051169 | nuclear transport(GO:0051169) |
0.1 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 1.5 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.9 | GO:0051899 | membrane depolarization(GO:0051899) |
0.1 | 1.8 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.1 | GO:0019320 | hexose catabolic process(GO:0019320) |
0.1 | 0.1 | GO:0051597 | response to methylmercury(GO:0051597) |
0.1 | 0.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 1.5 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.8 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.1 | 0.1 | GO:0017145 | stem cell division(GO:0017145) |
0.1 | 0.8 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
0.1 | 5.0 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.2 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.1 | 0.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.5 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.3 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.3 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 1.8 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 0.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.6 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.5 | GO:0060324 | face development(GO:0060324) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.3 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 1.1 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.1 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 1.3 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.1 | 0.2 | GO:0030318 | melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
0.1 | 0.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 1.6 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.4 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.1 | GO:0009147 | pyrimidine nucleoside triphosphate metabolic process(GO:0009147) |
0.1 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.5 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.1 | 0.3 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.1 | 2.1 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) cell cycle G2/M phase transition(GO:0044839) |
0.1 | 0.7 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.1 | 0.8 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 0.6 | GO:1901072 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 0.4 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.1 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.3 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 1.4 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
0.1 | 0.3 | GO:0015793 | glycerol transport(GO:0015793) |
0.1 | 0.4 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.1 | GO:0010874 | regulation of cholesterol efflux(GO:0010874) |
0.1 | 0.3 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.1 | 0.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.1 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.1 | 0.5 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.2 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.1 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.1 | 0.3 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) positive regulation of neuron death(GO:1901216) |
0.1 | 0.7 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.1 | 0.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.1 | GO:2000573 | positive regulation of DNA biosynthetic process(GO:2000573) |
0.1 | 0.1 | GO:0007492 | endoderm development(GO:0007492) |
0.1 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.2 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.1 | 0.5 | GO:0034762 | regulation of transmembrane transport(GO:0034762) |
0.1 | 0.9 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.2 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 1.2 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.1 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.1 | 0.2 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.5 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.8 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.3 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.7 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.1 | 0.2 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.2 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.1 | 0.2 | GO:0060192 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
0.1 | 0.2 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.1 | 0.2 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 0.1 | GO:0072659 | protein localization to plasma membrane(GO:0072659) protein localization to cell periphery(GO:1990778) |
0.1 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.2 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.1 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.1 | 0.1 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.1 | 0.1 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.1 | 0.9 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.1 | 0.1 | GO:2000278 | regulation of telomerase activity(GO:0051972) negative regulation of telomerase activity(GO:0051974) regulation of DNA biosynthetic process(GO:2000278) negative regulation of DNA biosynthetic process(GO:2000279) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.1 | GO:0051896 | regulation of protein kinase B signaling(GO:0051896) |
0.1 | 0.1 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.1 | GO:0002886 | regulation of myeloid leukocyte mediated immunity(GO:0002886) |
0.1 | 0.2 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.2 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.1 | 0.6 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 1.3 | GO:0043065 | positive regulation of apoptotic process(GO:0043065) |
0.1 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.1 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft organization(GO:0031579) membrane raft distribution(GO:0031580) membrane raft localization(GO:0051665) |
0.1 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 1.4 | GO:0006325 | chromatin organization(GO:0006325) |
0.1 | 0.1 | GO:0098657 | neurotransmitter uptake(GO:0001504) import into cell(GO:0098657) |
0.1 | 0.1 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.1 | 0.9 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.3 | GO:1901862 | negative regulation of muscle tissue development(GO:1901862) |
0.1 | 0.4 | GO:0044770 | cell cycle phase transition(GO:0044770) |
0.1 | 0.1 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.1 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 0.5 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 2.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.7 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.1 | 1.4 | GO:0042384 | cilium assembly(GO:0042384) |
0.1 | 0.5 | GO:0009791 | post-embryonic development(GO:0009791) |
0.1 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.1 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.1 | 0.1 | GO:0021591 | ventricular system development(GO:0021591) lateral ventricle development(GO:0021670) |
0.1 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.1 | GO:0034121 | regulation of toll-like receptor signaling pathway(GO:0034121) positive regulation of toll-like receptor signaling pathway(GO:0034123) |
0.1 | 0.1 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.5 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.1 | GO:0001974 | blood vessel remodeling(GO:0001974) |
0.1 | 0.4 | GO:0019682 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.1 | 0.1 | GO:0061430 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.1 | 0.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.1 | 4.3 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.1 | 0.2 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.1 | 0.1 | GO:0042752 | regulation of circadian rhythm(GO:0042752) |
0.1 | 0.2 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.1 | 0.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.1 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.1 | 0.2 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 1.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.2 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.1 | 0.4 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 3.3 | GO:0009615 | response to virus(GO:0009615) |
0.1 | 0.2 | GO:0042168 | heme metabolic process(GO:0042168) |
0.1 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.1 | GO:1903429 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.1 | 0.1 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.1 | 0.5 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.7 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.2 | GO:0051341 | regulation of oxidoreductase activity(GO:0051341) |
0.1 | 1.5 | GO:0045786 | negative regulation of cell cycle(GO:0045786) |
0.1 | 0.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.2 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 4.5 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.2 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.1 | 0.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.3 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 0.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.9 | GO:0030816 | positive regulation of cAMP metabolic process(GO:0030816) positive regulation of cAMP biosynthetic process(GO:0030819) |
0.1 | 0.5 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 1.8 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.2 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.1 | 0.1 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.1 | 0.2 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 0.1 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.1 | 0.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.3 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.7 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 0.7 | GO:0001906 | cell killing(GO:0001906) |
0.0 | 0.0 | GO:0007442 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.0 | 1.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.0 | 0.4 | GO:0015992 | proton transport(GO:0015992) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.2 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
0.0 | 0.5 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.2 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.0 | 0.0 | GO:0048670 | collateral sprouting(GO:0048668) regulation of collateral sprouting(GO:0048670) |
0.0 | 0.0 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.0 | 0.0 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.0 | 0.0 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.0 | 0.2 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.0 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 15.3 | GO:0015031 | protein transport(GO:0015031) |
0.0 | 0.0 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.0 | 0.4 | GO:0006974 | cellular response to DNA damage stimulus(GO:0006974) |
0.0 | 0.1 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.0 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.0 | GO:0072028 | nephron morphogenesis(GO:0072028) nephron epithelium morphogenesis(GO:0072088) |
0.0 | 0.1 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 1.1 | GO:0019395 | fatty acid oxidation(GO:0019395) lipid oxidation(GO:0034440) |
0.0 | 0.2 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.1 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.0 | 0.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.7 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.0 | 0.2 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.2 | GO:0050773 | regulation of dendrite development(GO:0050773) |
0.0 | 0.0 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.2 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.0 | 0.0 | GO:0034248 | regulation of cellular amide metabolic process(GO:0034248) |
0.0 | 0.3 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.0 | 0.1 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.0 | 0.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.0 | GO:0045123 | cellular extravasation(GO:0045123) |
0.0 | 0.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.7 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.0 | 0.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:0048599 | oocyte differentiation(GO:0009994) oocyte development(GO:0048599) |
0.0 | 0.0 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.1 | GO:0051262 | protein tetramerization(GO:0051262) |
0.0 | 1.2 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.0 | 0.4 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.0 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.0 | 0.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0006692 | prostanoid metabolic process(GO:0006692) |
0.0 | 0.0 | GO:0048799 | ossification involved in bone maturation(GO:0043931) organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.0 | 0.4 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
0.0 | 0.1 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.0 | 0.1 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.0 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.0 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
0.0 | 0.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.2 | GO:0043254 | regulation of protein complex assembly(GO:0043254) |
0.0 | 0.2 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.0 | 0.1 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.0 | 3.0 | GO:0007049 | cell cycle(GO:0007049) |
0.0 | 0.6 | GO:0006518 | peptide metabolic process(GO:0006518) |
0.0 | 0.1 | GO:0001656 | metanephros development(GO:0001656) |
0.0 | 0.0 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.3 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.1 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.0 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 2.3 | GO:0006869 | lipid transport(GO:0006869) |
0.0 | 0.6 | GO:0006096 | glycolytic process(GO:0006096) ATP generation from ADP(GO:0006757) |
0.0 | 0.1 | GO:0043206 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.0 | 0.1 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.0 | 0.0 | GO:0060177 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 27.8 | GO:0032774 | RNA biosynthetic process(GO:0032774) |
0.0 | 0.0 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.1 | GO:0000302 | response to reactive oxygen species(GO:0000302) |
0.0 | 0.0 | GO:0033604 | negative regulation of catecholamine secretion(GO:0033604) |
0.0 | 0.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.0 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.0 | 0.3 | GO:0030163 | protein catabolic process(GO:0030163) |
0.0 | 0.0 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.0 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.0 | 0.0 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.0 | 0.2 | GO:0030278 | regulation of ossification(GO:0030278) |
0.0 | 0.1 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.5 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.0 | 0.1 | GO:0031644 | regulation of neurological system process(GO:0031644) |
0.0 | 0.3 | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0007178) |
0.0 | 0.0 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.0 | 0.0 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.0 | GO:0017157 | regulation of exocytosis(GO:0017157) |
0.0 | 0.9 | GO:0007517 | muscle organ development(GO:0007517) |
0.0 | 0.0 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.0 | GO:0002762 | negative regulation of myeloid leukocyte differentiation(GO:0002762) |
0.0 | 0.1 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
0.0 | 0.0 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.0 | 4.2 | GO:0006508 | proteolysis(GO:0006508) |
0.0 | 0.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.0 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.0 | 0.0 | GO:0070509 | calcium ion import(GO:0070509) |
0.0 | 0.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.2 | GO:0006644 | phospholipid metabolic process(GO:0006644) |
0.0 | 0.0 | GO:0007369 | gastrulation(GO:0007369) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 5.7 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.9 | 2.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.9 | 2.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.8 | 5.0 | GO:0042382 | paraspeckles(GO:0042382) |
0.8 | 2.3 | GO:0072487 | MSL complex(GO:0072487) |
0.8 | 3.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.8 | 2.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.7 | 3.0 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.7 | 2.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.7 | 2.9 | GO:0005827 | polar microtubule(GO:0005827) |
0.7 | 3.5 | GO:0016589 | NURF complex(GO:0016589) |
0.7 | 0.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.6 | 6.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.6 | 2.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.6 | 3.1 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.6 | 4.7 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.6 | 2.9 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.6 | 1.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.6 | 2.2 | GO:0070820 | tertiary granule(GO:0070820) |
0.5 | 4.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 3.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.5 | 4.9 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.5 | 1.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.5 | 4.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.5 | 8.5 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.5 | 4.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 1.0 | GO:0016528 | sarcoplasm(GO:0016528) |
0.5 | 20.4 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.5 | 2.9 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.5 | 1.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.5 | 1.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.5 | 0.5 | GO:0010369 | chromocenter(GO:0010369) |
0.5 | 1.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.5 | 3.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.5 | 2.3 | GO:0070695 | FHF complex(GO:0070695) |
0.5 | 5.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.5 | 2.3 | GO:0000796 | condensin complex(GO:0000796) |
0.5 | 3.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.4 | 1.8 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.4 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 7.9 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.4 | 2.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.4 | 5.7 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.4 | 1.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.4 | 2.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.4 | 6.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.4 | 1.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 1.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.4 | 2.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.4 | 3.4 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.4 | 1.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 1.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 2.5 | GO:0070822 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.4 | 4.2 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.4 | 1.2 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.4 | 1.6 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.4 | 4.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 27.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.4 | 0.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 12.4 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 0.8 | GO:0005683 | U7 snRNP(GO:0005683) |
0.4 | 1.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.4 | 6.2 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.4 | 1.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.4 | 1.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.4 | 1.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 3.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 0.4 | GO:0001940 | male pronucleus(GO:0001940) |
0.4 | 1.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 3.0 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 2.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.4 | 2.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.4 | 3.3 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.4 | 7.0 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.4 | 0.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.4 | 12.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.4 | 0.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.4 | 1.8 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.4 | 2.1 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.4 | 1.4 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 11.7 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.4 | 4.6 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.4 | 0.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.4 | 1.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 1.7 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.3 | 1.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 1.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 2.7 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.3 | 3.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 1.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.3 | 2.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 13.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.3 | 19.8 | GO:0044815 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.3 | 2.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 1.6 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.3 | 2.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.3 | 1.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.3 | 3.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.3 | 1.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 17.3 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.3 | 25.2 | GO:0016607 | nuclear speck(GO:0016607) |
0.3 | 1.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.3 | 1.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.3 | 12.3 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.3 | 2.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 17.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.3 | 2.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 0.9 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.3 | 7.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 3.0 | GO:0008278 | cohesin complex(GO:0008278) |
0.3 | 1.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 0.9 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.3 | 3.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 0.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.3 | 1.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 0.9 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 2.3 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.3 | 0.6 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 4.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.3 | 0.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.3 | 13.2 | GO:0016605 | PML body(GO:0016605) |
0.3 | 0.9 | GO:0032059 | bleb(GO:0032059) |
0.3 | 0.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 1.1 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 5.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 1.4 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.3 | 0.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 0.6 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.3 | 0.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 3.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.3 | 0.6 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.3 | 2.5 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.3 | 3.4 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.3 | 0.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 1.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 23.2 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 1.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 1.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 1.9 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.3 | 0.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 0.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 10.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.3 | 5.7 | GO:0035097 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.3 | 1.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 1.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 9.4 | GO:0005814 | centriole(GO:0005814) |
0.3 | 1.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.3 | 1.1 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.3 | 2.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 7.1 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.3 | 3.9 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.3 | 1.3 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 2.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 21.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 10.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 1.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 2.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 5.5 | GO:0070469 | respiratory chain(GO:0070469) |
0.2 | 1.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 1.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 0.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 1.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 3.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 0.7 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.2 | 4.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.5 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.2 | 1.2 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 0.7 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 3.9 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 0.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.7 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 18.2 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 14.7 | GO:0005840 | ribosome(GO:0005840) |
0.2 | 2.5 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.2 | 1.6 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.2 | 29.5 | GO:0005769 | early endosome(GO:0005769) |
0.2 | 4.5 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.2 | 0.9 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.2 | 1.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 4.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 1.8 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 0.7 | GO:1902555 | tRNA-intron endonuclease complex(GO:0000214) endoribonuclease complex(GO:1902555) |
0.2 | 1.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 1.5 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.8 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 1.3 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 1.0 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 0.8 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 0.6 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 14.2 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.2 | 0.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.2 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.2 | 0.8 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.2 | 3.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 18.0 | GO:0000785 | chromatin(GO:0000785) |
0.2 | 7.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 0.8 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 1.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 2.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 6.1 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.2 | 1.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 0.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 1.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 1.9 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.2 | 5.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 0.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 1.7 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 1.3 | GO:0005844 | polysome(GO:0005844) |
0.2 | 3.5 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.2 | 4.4 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 0.2 | GO:0031430 | M band(GO:0031430) |
0.2 | 0.2 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 0.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 1.1 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 0.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 1.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 2.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 1.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 1.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.7 | GO:0030120 | vesicle coat(GO:0030120) |
0.2 | 6.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 0.2 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 0.8 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 2.7 | GO:0030496 | midbody(GO:0030496) |
0.2 | 0.5 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.2 | 0.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 24.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 0.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 4.6 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 2.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 7.0 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.2 | 6.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 1.8 | GO:1990391 | DNA repair complex(GO:1990391) |
0.2 | 0.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 1.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 0.8 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 0.5 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 1.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 108.1 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 0.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 179.7 | GO:0005829 | cytosol(GO:0005829) |
0.2 | 0.5 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 1.3 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.1 | 0.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 7.1 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 5.0 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 67.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.1 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.5 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 2.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 4.0 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 1.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.4 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 19.8 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.4 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 0.9 | GO:0012505 | endomembrane system(GO:0012505) |
0.1 | 1.4 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.5 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.7 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.4 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 1.1 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 1.1 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 21.2 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 1.3 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.1 | 0.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 230.7 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 6.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.5 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 9.1 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 0.3 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.2 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 29.3 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.1 | 0.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.8 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.1 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.3 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.2 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.1 | 0.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 2.4 | GO:0005929 | cilium(GO:0005929) |
0.1 | 0.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 7.7 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.3 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.1 | 1.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.2 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.1 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.0 | 0.3 | GO:1990234 | transferase complex(GO:1990234) |
0.0 | 0.0 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.1 | GO:0044437 | vacuolar part(GO:0044437) |
0.0 | 2.0 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.0 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.1 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.8 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 2.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.0 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.1 | GO:0099738 | apical cortex(GO:0045179) cell cortex region(GO:0099738) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 4.3 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 2.3 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.0 | 0.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.1 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 28.2 | GO:0005622 | intracellular(GO:0005622) |
0.0 | 0.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.3 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 1.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
1.2 | 3.6 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
1.0 | 3.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.9 | 2.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.8 | 4.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.8 | 2.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.8 | 9.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.8 | 2.4 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.8 | 0.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.8 | 0.8 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.8 | 3.1 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.7 | 4.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.7 | 2.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.7 | 2.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.7 | 2.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.7 | 4.0 | GO:0005521 | lamin binding(GO:0005521) |
0.7 | 2.0 | GO:0005113 | patched binding(GO:0005113) |
0.6 | 2.6 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.6 | 1.9 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.6 | 1.9 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.6 | 1.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.6 | 1.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.6 | 1.8 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.6 | 1.8 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.6 | 3.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.6 | 3.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.6 | 2.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.6 | 2.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.6 | 1.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.6 | 4.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.6 | 1.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.6 | 1.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.6 | 0.6 | GO:0004775 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.6 | 1.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.5 | 1.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.5 | 1.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.5 | 1.6 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.5 | 1.6 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.5 | 0.5 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.5 | 1.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 21.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.5 | 2.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.5 | 3.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.5 | 1.6 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.5 | 4.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.5 | 1.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.5 | 3.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.5 | 0.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.5 | 2.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.5 | 1.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.5 | 2.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.5 | 1.9 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.5 | 1.4 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.5 | 2.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.5 | 2.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.5 | 1.9 | GO:0045502 | dynein binding(GO:0045502) |
0.5 | 1.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.5 | 2.8 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.5 | 1.4 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.5 | 0.5 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.5 | 0.9 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.5 | 1.8 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.5 | 1.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.5 | 1.8 | GO:0030371 | translation repressor activity(GO:0030371) |
0.5 | 1.8 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.4 | 1.8 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.4 | 4.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.4 | 1.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 0.9 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.4 | 8.9 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
0.4 | 0.4 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.4 | 2.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.4 | 0.4 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.4 | 2.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 1.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.4 | 3.5 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 3.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.4 | 1.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.4 | 1.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 3.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 0.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.4 | 1.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.4 | 3.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.4 | 1.7 | GO:0045569 | TRAIL binding(GO:0045569) |
0.4 | 1.3 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.4 | 1.3 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.4 | 1.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.4 | 1.3 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.4 | 1.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.4 | 12.1 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.4 | 2.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.4 | 1.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.4 | 1.6 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.4 | 3.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 2.0 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.4 | 2.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 0.8 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.4 | 1.6 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 3.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.4 | 2.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 1.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 1.6 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.4 | 1.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.4 | 1.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 1.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.4 | 1.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.4 | 3.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.4 | 1.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.4 | 1.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 3.4 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.4 | 1.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 1.5 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.4 | 0.8 | GO:0003917 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
0.4 | 1.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.4 | 0.4 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.4 | 1.5 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.4 | 0.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.4 | 7.1 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.4 | 0.4 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.4 | 0.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.4 | 1.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.4 | 1.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.4 | 4.0 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.4 | 0.4 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.4 | 0.7 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.4 | 0.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 9.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.4 | 1.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.4 | 6.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 4.9 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.3 | 8.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.3 | 0.3 | GO:0044620 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.3 | 1.0 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 1.7 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.3 | 2.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 12.7 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.3 | 11.0 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.3 | 1.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 4.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.3 | 1.0 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.3 | 1.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.3 | 1.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 4.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 1.7 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.3 | 1.0 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 4.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 1.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 1.3 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.3 | 6.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.3 | 3.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 1.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 1.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.3 | 1.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 1.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 1.6 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.3 | 2.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 1.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 4.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 0.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.3 | 9.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 10.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.3 | 1.6 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.3 | 1.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.3 | 2.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 1.9 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.3 | 1.6 | GO:0015923 | mannosidase activity(GO:0015923) |
0.3 | 1.2 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.3 | 0.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 0.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.3 | 1.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 1.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 0.9 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.3 | 0.3 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.3 | 1.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 14.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 1.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 45.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.3 | 2.1 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 6.4 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
0.3 | 10.6 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.3 | 1.8 | GO:0061630 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.3 | 0.9 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.3 | 0.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 1.8 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 1.2 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.3 | 0.9 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 0.3 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.3 | 1.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 1.2 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.3 | 0.9 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.3 | 1.2 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 1.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 1.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 7.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.3 | 2.0 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.3 | 2.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 1.7 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.3 | 2.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 0.9 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 0.9 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.3 | 21.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.3 | 1.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 1.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 1.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.3 | 4.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.3 | 6.5 | GO:0019003 | GDP binding(GO:0019003) |
0.3 | 0.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 1.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.3 | 9.8 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.3 | 0.8 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.3 | 1.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 2.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 0.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 8.6 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.3 | 1.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.3 | 1.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 1.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.3 | 3.8 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.3 | 1.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 0.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.3 | 1.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 1.4 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.3 | 2.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.3 | 2.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.3 | 2.1 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.3 | 0.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 1.3 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.3 | 2.1 | GO:0017069 | snRNA binding(GO:0017069) |
0.3 | 0.8 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.3 | 0.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 0.3 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.3 | 2.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 0.3 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.3 | 0.8 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.3 | 1.8 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.3 | 0.5 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.3 | 0.8 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.3 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 2.6 | GO:0005048 | signal sequence binding(GO:0005048) |
0.3 | 0.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 1.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 0.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.3 | 3.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 1.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 0.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 14.1 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.3 | 1.5 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 0.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 1.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.2 | GO:0004875 | complement receptor activity(GO:0004875) |
0.2 | 1.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 2.7 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.2 | 48.0 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.2 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 1.5 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.2 | 0.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.2 | 1.5 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.0 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 1.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 2.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 1.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 0.5 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.2 | 0.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 1.9 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.2 | 2.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 1.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 2.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 2.6 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.2 | 0.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 0.9 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 0.7 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 2.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 0.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 1.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 0.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.2 | 4.9 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.7 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 0.7 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 8.0 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.2 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.7 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.2 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 0.9 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 1.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 1.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.2 | 0.4 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.2 | 1.6 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.2 | 4.5 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.2 | 0.7 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 1.6 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.9 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 0.7 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.2 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.9 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 0.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 0.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 2.0 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.2 | 1.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 1.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 0.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 2.6 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 0.9 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 3.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 4.8 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 95.4 | GO:0003723 | RNA binding(GO:0003723) |
0.2 | 2.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 9.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 1.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 3.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 1.7 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.2 | 0.8 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.2 | 1.9 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.2 | 0.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 0.6 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.2 | 0.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 1.4 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.6 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.2 | 5.5 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 1.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 1.6 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.2 | 0.6 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.2 | 0.6 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 1.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 0.4 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.2 | 0.6 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.2 | 0.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 1.6 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.2 | 0.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 1.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 0.6 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 0.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 0.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 0.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 4.2 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 0.2 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.2 | 0.2 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.2 | 3.6 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 1.0 | GO:0032451 | demethylase activity(GO:0032451) |
0.2 | 1.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.8 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.2 | 4.7 | GO:0051287 | NAD binding(GO:0051287) |
0.2 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 1.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.4 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.2 | 0.6 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 2.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.8 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 0.9 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 5.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 1.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 16.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 1.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 1.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.2 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 0.4 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.2 | 1.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 29.0 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 2.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.2 | 2.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.2 | 0.5 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.2 | 6.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.2 | 1.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 3.0 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 1.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 1.9 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 3.3 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.2 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.2 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.2 | 2.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 4.4 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.2 | 0.8 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.2 | 0.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 0.5 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.2 | 0.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 0.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 0.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.2 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.8 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.2 | 1.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 2.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 0.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 1.9 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 0.8 | GO:0019213 | deacetylase activity(GO:0019213) |
0.2 | 0.6 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.2 | 0.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 0.6 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 2.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 0.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 0.3 | GO:0051379 | beta-adrenergic receptor activity(GO:0004939) epinephrine binding(GO:0051379) norepinephrine binding(GO:0051380) |
0.2 | 1.4 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 0.5 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.2 | 0.6 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 0.8 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.2 | 0.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 0.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 3.3 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 0.9 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 1.0 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.1 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 0.6 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 9.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 1.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 0.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 1.8 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 1.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 2.4 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.1 | 0.3 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 1.5 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 2.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 2.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 1.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 5.3 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.4 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.1 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 7.3 | GO:0016741 | transferase activity, transferring one-carbon groups(GO:0016741) |
0.1 | 0.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.1 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 1.5 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 1.5 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 4.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 1.8 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 0.6 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 1.9 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.1 | 8.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.7 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.5 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.5 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 6.4 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 0.4 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 1.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 13.9 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 1.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 1.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 3.4 | GO:0016407 | acetyltransferase activity(GO:0016407) |
0.1 | 0.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 169.1 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 1.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.4 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 3.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 1.2 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.1 | 1.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 3.9 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 1.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 1.0 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 0.2 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 0.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 2.3 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 1.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.2 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.1 | 1.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 7.8 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 1.1 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.1 | 0.5 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.1 | 0.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 2.2 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.4 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 1.0 | GO:0016887 | ATPase activity(GO:0016887) |
0.1 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 1.3 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 0.6 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 0.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 7.3 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 1.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.9 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 4.1 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.3 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.1 | 0.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.4 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 1.7 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 0.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.6 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 0.2 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 0.7 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.6 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.8 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 20.4 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.6 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.4 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 0.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 1.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.8 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.5 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 1.2 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.5 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 12.8 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.1 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.1 | 0.3 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.1 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 5.7 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.1 | 2.8 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 1.1 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.4 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.5 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 1.4 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 50.4 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 1.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.4 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 6.8 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.1 | 1.0 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.1 | 0.2 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.1 | 3.2 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 1.3 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 1.6 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.3 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 1.1 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.2 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.2 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 1.3 | GO:0019900 | kinase binding(GO:0019900) |
0.0 | 0.6 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.2 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.1 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.2 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.0 | 0.2 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.2 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.0 | 0.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.2 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 2.9 | GO:0016788 | hydrolase activity, acting on ester bonds(GO:0016788) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.2 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.1 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.0 | GO:0005035 | death receptor activity(GO:0005035) |
0.0 | 0.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 2.9 | GO:0008233 | peptidase activity(GO:0008233) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.0 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.3 | GO:0016301 | kinase activity(GO:0016301) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 55.2 | GO:0005515 | protein binding(GO:0005515) |
0.0 | 4.4 | GO:0017076 | purine nucleotide binding(GO:0017076) |
0.0 | 0.0 | GO:0042887 | amide transmembrane transporter activity(GO:0042887) |
0.0 | 0.0 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.5 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.0 | 0.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.0 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.0 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 0.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.5 | 9.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.5 | 0.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.4 | 6.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 12.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 4.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 2.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.4 | 0.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.4 | 8.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 5.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.4 | 3.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.4 | 3.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 11.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.4 | 1.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 8.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 12.0 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 1.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 10.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 6.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 2.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 3.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 6.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 12.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 13.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 3.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 6.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 3.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 2.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 18.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 2.1 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 7.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 3.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 3.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 3.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 7.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 10.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 1.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 0.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 3.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 11.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 0.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 2.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 1.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 4.9 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 2.3 | PID ATM PATHWAY | ATM pathway |
0.2 | 6.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 1.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 1.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 3.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 3.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 1.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 4.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 6.8 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 2.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 0.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 1.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 1.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 2.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 0.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 2.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 0.8 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 1.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 3.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 2.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 1.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 1.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 1.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 3.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 1.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 2.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 2.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 1.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.3 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.5 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 2.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 2.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 3.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 2.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 2.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 3.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 2.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 3.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 2.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 1.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.5 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 3.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.5 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 1.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.7 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.7 | 2.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.6 | 6.1 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.6 | 12.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.5 | 9.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.5 | 1.5 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.5 | 30.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.5 | 8.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.5 | 8.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.4 | 18.9 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.4 | 3.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 7.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.4 | 5.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.4 | 1.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.4 | 0.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.4 | 3.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 7.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 4.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.4 | 5.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 7.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.4 | 5.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.4 | 2.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 4.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.4 | 1.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.4 | 6.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 0.8 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.4 | 5.9 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.4 | 10.4 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.4 | 22.3 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
0.4 | 6.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.4 | 1.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 6.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.4 | 4.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.4 | 13.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.4 | 2.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 6.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.4 | 0.7 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.4 | 3.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 16.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 2.8 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.3 | 7.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 5.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 3.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.3 | 6.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.3 | 8.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 9.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 5.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 2.0 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.3 | 3.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 3.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 20.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.3 | 0.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 4.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 13.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.3 | 2.8 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 1.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.3 | 5.2 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.3 | 15.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 5.8 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.3 | 3.0 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.3 | 3.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.3 | 0.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.3 | 3.0 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.3 | 2.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 21.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.3 | 4.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 3.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 1.8 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.3 | 4.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.3 | 11.6 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.3 | 4.3 | REACTOME TRANSLATION | Genes involved in Translation |
0.3 | 0.9 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.3 | 3.4 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.3 | 4.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.3 | 12.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.3 | 0.3 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.3 | 1.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 2.2 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.3 | 0.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.3 | 2.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 4.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 6.3 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.3 | 3.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 0.8 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 0.2 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 0.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 2.5 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.2 | 1.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 10.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 4.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 3.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 1.0 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.2 | 1.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 0.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 3.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 8.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 1.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 3.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 5.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 1.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 0.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 1.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 2.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 1.5 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.2 | 0.2 | REACTOME S PHASE | Genes involved in S Phase |
0.2 | 1.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 4.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 24.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 3.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 0.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 3.6 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 3.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 3.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 2.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.2 | 1.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 2.0 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 4.4 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.2 | 3.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 5.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 2.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 1.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.2 | 3.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 0.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 1.0 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 2.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 3.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 1.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 0.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 2.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 1.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 1.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 3.9 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 1.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 6.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 0.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 0.8 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.2 | 0.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 0.6 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 0.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 2.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 7.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 3.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 2.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.9 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 4.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.3 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.1 | 0.3 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.1 | 1.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 2.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.1 | 2.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 36.5 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 5.0 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 2.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.9 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 3.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 1.0 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.6 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 1.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 2.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 2.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.4 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.1 | 0.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.1 | REACTOME HIV INFECTION | Genes involved in HIV Infection |
0.1 | 1.0 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.7 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 1.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 0.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 3.6 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 1.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 1.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.5 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.1 | 5.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.2 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.1 | 1.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 4.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 2.8 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 3.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.2 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.1 | 0.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 1.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 1.2 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.1 | 0.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 2.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.5 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 1.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.5 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 1.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 1.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.2 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 1.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.1 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.0 | 0.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.9 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.0 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.0 | 0.0 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.0 | 0.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |